The Optical Genome Mapping Market has experienced significant growth in recent years, driven by the rising demand for advanced genomic analysis tools and techniques. This innovative technology provides researchers and clinicians with a powerful method to study structural variations in the genome, enhancing their understanding of genetic diseases and paving the way for advancements in personalized medicine.
NEWARK, Del, July 16, 2024 (GLOBE NEWSWIRE) — The global Optical Genome Mapping Market will reach a valuation of USD 167.0 million in 2024, attributed to factors including regulatory harmonization and standardization. The trend is set to create new opportunities for the market, leading to a projected CAGR of 23.5% between 2024 and 2034, and reaching a total valuation of approximately USD 1.3 billion by 2034.
Optical genome mapping holds potential for early detection of genetic diseases and conditions. The technology enables early diagnosis, intervention, and personalized treatment strategies, by accurately identifying structural variations and chromosomal abnormalities in patient genomes.
Optical genome mapping is increasingly being utilized in cancer research and precision oncology for comprehensive profiling of tumor genomes. Optical genome mapping aids in the characterization of cancer genomes, guiding treatment decisions and drug development efforts, by identifying genomic alterations, including structural variations and copy number variations.
Request a Sample Copy of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-19525
Optical genome mapping is increasingly being used in rare disease research to identify novel genetic variants and disease causing mutations. The high resolution analysis capabilities of this technology facilitate the discovery of rare and elusive genetic alterations.
Integration of optical genome mapping data with clinical decision support systems enhances the utility of genomic information in healthcare settings. The integration improves diagnostic accuracy, treatment selection, and patient management, by providing clinicians with actionable insights and treatment recommendations based on genomic data.
There is a growing interest in the development of portable and point of care optical genome mapping devices. The compact, user friendly platforms enable decentralized genomic analysis, bringing genomic technologies closer to the point of patient care.
The growing adoption of optical genome mapping in clinical diagnostics is driving the expansion of genetic counseling services. Genetic counselors play a crucial role in interpreting and communicating genomic information to patients and their families, helping them make informed decisions about healthcare, family planning, and genetic testing.
Integration of optical genome mapping with liquid biopsy technologies enhances the detection and monitoring of cancer and other diseases. The integrated approach enables non-invasive detection of genetic alterations, disease progression, and treatment response, by analyzing cell free DNA and circulating tumor DNA.
Key Takeaways from the Optical Genome Mapping Market Study
- The global optical genome mapping market was valued at USD 131.5 million in 2023.
- From 2019 to 2023, the market demand expanded at a CAGR of 28.0%.
- The market in Korea to expand at a CAGR of 26.0% through 2034.
- By component, the instruments segment to account for a CAGR of 23.2% through 2034.
- The market in China will expand at a CAGR of 24.4% through 2034.
- In terms of application, the research segment to account for a CAGR of 23.0% through 2034.
“Optical genome mapping is finding applications in forensic genetics for human identification, ancestry determination, and forensic DNA analysis,” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Optical Genome Mapping Market from the Competitive Landscape:
Prominent players in the optical genome mapping market are Bionano Genomics, Inc., Nucleome Informatics Private Limited, Nabsys, Inc., Praxis Genomics LLC, PerkinElmer, Inc., OpGen, Inc., SourceBio International Limited, MedGenome Labs Private Limited, Genohub Inc., and Cerba HealthCare, among others.
Company Portfolio
- OpGen, Inc. is a molecular diagnostics company that develops solutions for infectious disease testing, antimicrobial resistance surveillance, and genomic analysis. They offer products and services that utilize genomic technologies for pathogen detection and characterization.
- Praxis Genomics LLC is a molecular diagnostics company specializing in genetic testing services and genomic analysis. Praxis Genomics provides genetic testing for inherited disorders, cancer risk assessment, pharmacogenomics, and other clinical applications.
Get in Touch with Our Sales Team to Secure Your Copy of the Report Now! https://www.futuremarketinsights.com/checkout/19525
Key Companies Profiled in the Optical Genome Mapping Market:
- Bionano Genomics Inc.
- Nucleome Informatics Private Limited
- Nabsys Inc.
- Praxis Genomics LLC
- PerkinElmer Inc.
- OpGen Inc.
- SourceBio International Limited
- MedGenome Labs Private Limited
- Genohub Inc.
- Cerba HealthCare
Segmentation Analysis of the Optical Genome Mapping Market
By Component:
- Instruments
- Consumables and Reagents
- Services and Software
By Application:
- Research
- Diagnostics
By Solution:
- Structural Variant Detection
- Genome Assembly
- Microbial Strain Typing
- Other Solutions
By End Use:
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
- Diagnostic Laboratories
- Other End Users
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Authored by
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at the Related Report from the Optical Genome Mapping Market:
The global optical coherence tomography market size reached USD 1,311.70 million in 2023. Growth of optical coherence tomography sales is anticipated to hit USD 3,250.70 million by 2033
The clinical oncology next-generation sequencing market size stands at USD 635 million in 2024. The clinical oncology NGS market size is set to rise at a 17.3% CAGR through 2034.
The optical imaging market share is estimated to show consistent growth throughout the forecast period, expanding at a CAGR of 4.7%. The optical imaging market value is expected to expand from USD 1,465.4 million in 2024
The global gene editing tool market is on track to advance at a CAGR of 18.4% from 2024 to 2034. In 2024, the valuation is standing around USD 688.1 million and is projected to expand to USD 3,713.1 million by 2034.
The global clinical next-generation sequencing (NGS) data analysis market enjoys a valuation of USD 2.3 Billion in 2022, and it is further projected to expand at a CAGR of 17.4% over the forecasted years.
The CRISPR market had an estimated market share worth USD 3.4 billion in 2023, and it is predicted to reach a global market valuation of USD 17.8 billion by 2034, growing at a CAGR of 16.1% from 2024 to 2034.
The global personal genome testing market is forecast to be appraised at USD 4,468 Million by 2032, up from USD 1,545.5 Million in 2022, advancing at a CAGR of 10.1% during the forecast period.
The global digital health market value is estimated to be USD 8,131.3 million in 2024. The overall market is predicted to grow at a promising CAGR of 7.4% during the forecast period.
Current projections of molecular diagnostic market indicate an estimation of USD 60,347.40 million by 2034, climbing up from USD 39,611.00 million in 2024.
The global DNA diagnostics market garnered USD 20.9 Billion in 2021 and is likely to exhibit a Y-o-Y increase of 9.6% to be valued at USD 22.9 Billion in 2022.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
- CORRECTION – Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results - May 15, 2025
- Beztak Recognized as a US Best Managed Company andNational Multifamily Housing Council 2025 Top 50 Managers - May 15, 2025
- BranchOut Food Reports Record $3.2M in Q1 Revenue Following Peru Factory Ramp-Up, National Retail Expansion, and $5–6M Ingredient Channel Partnership - May 15, 2025
